JapanConsumer goods2023 – ongoingKOBAYASHI Pharmaceutical
In-house AI chatbot kAIbot and company-wide generative AI
KOBAYASHI Pharmaceutical's in-house chatbot grew into a generative AI platform used by about 3,700 staff
Problem
The company wanted employees to use generative AI safely in daily work and in its culture of proposing product ideas.
Approach
In 2023 the company launched kAIbot, an in-house chatbot built on Azure OpenAI Service. It first served an all-employee product-idea event. In 2025 it moved the platform to Gemini, which can safely use the files employees already hold in Google Workspace.
Results
Takeaway
Usage and speed figures come from company staff in an interview on a site run by an AI adoption vendor.
Categories
- Industry
- Consumer goods
- Business function
- Internal work and knowledge management
- Innovation type
- Process innovation
- AI technology
- Generative AI
- Adoption
- Built in-house
- Evidence
- Company's own claim
Sources
Source summaries
An interview with Kobayashi staff on a site run by SHIFT AI. It says kAIbot started in 2023, the platform moved to Gemini in 2025, and about 3,700 staff use generative AI with near-100% monthly usage. A manager says overall work is about three times faster.
Full details are in the original sources.